NCT06880081View on ClinicalTrials.gov

Study of PN20 in Adult Patients with Primary Immune Thrombocytopenia (ITP)

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

March 7, 2025

Primary Completion Date

October 28, 2025

Study Completion Date

October 28, 2025

Conditions
Primary Immune Thrombocytopenia (ITP)
Interventions
DRUG

PN20 treatment

Three dose cohorts, single dose, subcutaneous injections

Trial Locations (5)

272011

RECRUITING

Jining First People's Hospital, Jining

301609

RECRUITING

Hematology Hospital of Chinese Academy of Medical Sciences, Tianjin

330006

RECRUITING

The Second Affiliated Hospital of Nanchang University, Nanchang

550004

RECRUITING

Affiliated Hospital of Guizhou Medical University, Guiyang

650000

RECRUITING

The Second Affiliated Hospital of Kunming Medical University, Kunming

All Listed Sponsors
lead

Chongqing Peg-Bio Biopharm Co., Ltd.

INDUSTRY